TDS warns of continuing "Vishing" attempts ( M adison Wis. - Nearly a week since...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

TDS warns of continuing "Vishing" attempts

Madison, Wis. - Nearly a week since its first notification, TDS Telecom says telecommunications customers in Wisconsin, including several served by TDS, are still being approached by a fraudulent company offering significant reductions in long distance calling plans.

The scam is known as "Vishing," which is similar to online "Phishing"......

Full article >>>

Source:wistechnology.com By WTN News 07/20/06

Page: 1 2
Related biology technology :

1. Investor warns of angel-venture funding gap
2. Journalist warns against late arrival to the tech party
3. Rodney Dykehouse of Froedtert and Medical College of Wisconsin warns against tech for its own sake
4. Minnesota, Missouri see continuing health care investments; Wisconsin lags

Post Your Comments:

Breaking Biology Technology:Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6 Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3 Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4

[0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)[0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe

Other Biology Technology:BioMed Realty Trust Announces Increase in Quarterly Common Stock Dividend 2 Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference 2 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 2 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 3 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 4 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 5 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 6 Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 7

BioMed Realty Trust Announces Increase in Quarterly Common Stock Dividend Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference Renovis Reports Fourth Quarter and Full Year 2007 Financial Results

Breaking Biology News(10 mins):Type 2 diabetes gene predisposes children to obesity 2 New understanding of how to prevent destruction of a tumor suppressor 2 Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA 2 Wyeths Prevenar 13 Receives First Approval 51609 1 Wyeths Prevenar 13 Receives First Approval 51609 2 Wyeths Prevenar 13 Receives First Approval 51609 3 Wyeths Prevenar 13 Receives First Approval 51609 4 Wyeths Prevenar 13 Receives First Approval 51609 5 Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 1 Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 2 Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines 28R 29 for Medicare Medicaid Reviews 51607 3 China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 1 China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 2 China Sky One Medical Inc Obtains Renewal of GMP Certificate 51605 3

[0] Type 2 diabetes gene predisposes children to obesity [0] New understanding of how to prevent destruction of a tumor suppressor [0] Biogen Idec's oral compound BG-12 achieves development milestones in MS and RA

Other Biology News:A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 2 A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss 3 Strange travels 2 Registration Opens for 2009 Force Protection Equipment Demonstration 2

A BBVA Foundation project comes up with a system enabling detection of cetacean hearing loss Strange travels Registration Opens for 2009 Force Protection Equipment Demonstration

Biology Products:

ProteoSpin Maxi CBED Kit from Norgen Biotek Corporation Agilent Microarray hybridization Chamber Kits from Agilent Technologies McCown's Woody Plant Basal Salt Mixture from Sigma-Aldrich Human / Mouse / Rat Blood Vessels (CD31 / Von Willebrand Factor (vWF)) IHC staining Kit from CHEMICON